Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects

Table 2

Clinical, biochemical, and hormonal features according the CHD type in young CHD patients.

Markers	CHD1	CHD2	CHD3
	153	62	15
Age (years)	6.4; (4.3–9.2)	7.5; (3.8–10.3)	5.4; (2.6–6.7)	ns
Male/female	65/88	35/27	11/4	ns
HSDS	−0.13; (−1.07–0.59)	−0.54; (−1.42–0.44)	−0.92; (−2.29–0.42)	ns
(%)	98.0; (92.0–107.0)	98.5; (93.0–110.3)	93.0; (84.0–107.0)	ns
Creatinine; (mg/dL)	0.42; (0.36–0.50)	0.44; (0.36–0.55)	0.41; (0.35–0.45)	ns
Alb/calcium; (mg/dL)	9.02; (8.80–9.30)	9.06; (8.80–9.33)	8.81; (8.72–9.60)	ns
25OHD; (ng/mL)	19.0; (12.8–30.0)	21.3; (12.5–33.4)	17.9; (11.9–30.7)	ns
PTH; (pg/mL)	31.0; (22.0–44.5)	28.5; (20.5–41.0)	35.0; (26.0–59.0)	ns
NT-proBNP; (ng/mL)	104.6; (60.1–182.5)	109.8; (54.7–200.9)	70.0; (41.0–97.9)	ns

ns, not significant; Alb/calcium, albumin-corrected calcium; , weight/height; HSDS, height standard deviation score; ionized Ca, ionized calcium.